DK0956858T3 - Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner - Google Patents

Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner

Info

Publication number
DK0956858T3
DK0956858T3 DK98830264T DK98830264T DK0956858T3 DK 0956858 T3 DK0956858 T3 DK 0956858T3 DK 98830264 T DK98830264 T DK 98830264T DK 98830264 T DK98830264 T DK 98830264T DK 0956858 T3 DK0956858 T3 DK 0956858T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical preparations
preparations containing
vaginal infections
containing lactobacilli
Prior art date
Application number
DK98830264T
Other languages
English (en)
Inventor
Vesely Renata Maria Cavaliere
Simone Claudio De
Original Assignee
Vesely Renata Maria Cavaliere
Simone Claudio De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8236635&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0956858(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vesely Renata Maria Cavaliere, Simone Claudio De filed Critical Vesely Renata Maria Cavaliere
Application granted granted Critical
Publication of DK0956858T3 publication Critical patent/DK0956858T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
DK98830264T 1998-04-30 1998-04-30 Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner DK0956858T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98830264A EP0956858B1 (en) 1998-04-30 1998-04-30 Pharmaceutical compositions containing Lactobacillus brevis and Lactobacillus salivarius for treatment of vaginal infections

Publications (1)

Publication Number Publication Date
DK0956858T3 true DK0956858T3 (da) 2002-01-28

Family

ID=8236635

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98830264T DK0956858T3 (da) 1998-04-30 1998-04-30 Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner

Country Status (17)

Country Link
US (2) US6277370B1 (da)
EP (1) EP0956858B1 (da)
JP (1) JPH11322621A (da)
KR (1) KR100590839B1 (da)
CN (1) CN1263467C (da)
AR (1) AR017404A1 (da)
AT (1) ATE207755T1 (da)
AU (1) AU745286B2 (da)
BR (1) BR9900972A (da)
CA (1) CA2254548C (da)
DE (1) DE69802260T2 (da)
DK (1) DK0956858T3 (da)
ES (1) ES2165139T3 (da)
HK (1) HK1022439A1 (da)
HU (1) HU225491B1 (da)
PL (1) PL189577B1 (da)
PT (1) PT956858E (da)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6093394A (en) 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
AU4905300A (en) * 1999-05-25 2000-12-12 Andrew W. Bruce Oral administration of lactobacillus for the maintenance of health in women
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
JP4933714B2 (ja) * 2000-06-19 2012-05-16 ハンター・イミュノロジー・リミテッド カンジダ症の治療のための組成物および方法
DE60137235D1 (de) * 2000-08-25 2009-02-12 Wakamoto Pharma Co Ltd L. salivarius-Stamm enthaltende probiotische Produkte
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
US7179458B2 (en) * 2002-03-08 2007-02-20 Osel, Inc. Lactobacilli expressing biologically active polypeptides and uses thereof
AU2003215526B2 (en) 2002-03-21 2008-01-17 Bifodan A/S Lactobacillus strains
AU2003215472A1 (en) * 2002-03-28 2003-10-13 Jeremy Burton Lactobacillus iners for the enhancement of urogenital health
JP2004067599A (ja) * 2002-08-07 2004-03-04 Kunihiko Tominaga 腟内洗浄剤
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
BRPI0414500A (pt) * 2003-09-19 2006-11-07 Drugtech Corp formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
DE50300325D1 (de) * 2003-11-03 2005-03-31 Peter-Hansen Volkmann Vaginalpflegezusammensetzung
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
WO2006036406A2 (en) 2004-08-25 2006-04-06 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Live microbial microbicides
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
EP1802318A1 (en) * 2004-10-22 2007-07-04 Medinova AG Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
BRPI0419245A (pt) * 2004-12-23 2007-12-18 Vsl Pharmaceuticals Inc dispositivo e método para identificar e tratar afecções vaginais
WO2006083516A2 (en) * 2005-01-12 2006-08-10 Osel, Inc. Modified cyanovirin-n polypeptide
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
US20070082035A1 (en) * 2005-10-06 2007-04-12 New York Blood Center, Inc. Anti-infective hygiene products based on cellulose acetate phthalate
US20070224226A1 (en) * 2006-01-05 2007-09-27 Drugtech Corporation Composition and method of use thereof
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
ITMI20062286A1 (it) * 2006-11-28 2008-05-29 Anidral Srl Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
BRPI0808391A2 (pt) 2007-02-01 2014-07-08 Lams Company Método para diminuir a inflamação e o estresse em um mamífero, mediante o uso de antimetabólitos de glicose, abacate ou extratos de abacate.
AU2008256689A1 (en) * 2007-05-24 2008-12-04 New York Blood Center Inc. Rapidly dispersible vaginal tablet that provides a bioadhesive gel
PL210465B1 (pl) 2007-06-04 2012-01-31 Inst Biotechnologii Surowic I Szczepionek Biomed Społka Akcyjna Zastosowanie kompozycji szczepów z rodzaju Lactobacillus
CN102028224B (zh) * 2007-06-21 2012-12-26 东宇生物科技股份有限公司 抗过敏的乳酸菌
EP1930044B1 (en) * 2007-07-26 2017-08-23 Elisabetta Livi Two-phase vaginal lavage
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
TWI451871B (zh) * 2010-04-30 2014-09-11 Glac Biotech Co Ltd 用以抑制發炎反應及抗陰道炎之含乳酸菌食品組合物及醫藥組合物
TWI542353B (zh) * 2010-04-30 2016-07-21 豐華生物科技股份有限公司 用以抗陰道炎之含乳酸菌食品組合物及醫藥組合物
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
KR101355441B1 (ko) * 2011-11-03 2014-01-27 주식회사한국야쿠르트 질염 병원균의 증식을 억제하는 활성을 갖는 락토바실러스 존소니 에이취와이7042 및 이를 유효성분으로 함유하는 제품
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
WO2015173693A1 (en) * 2014-05-16 2015-11-19 Pizeta Group Srl Compositions containing boric acid and a mixture of lactobacillus
CN105287644B (zh) * 2015-09-14 2018-12-28 吉林农业大学 治疗奶牛隐性子宫内膜炎的益生菌组合活菌制剂
EP3167890A1 (de) 2015-11-12 2017-05-17 Glock Health, Science and Research GmbH Behandlung von vaginitis
FR3048361B1 (fr) * 2016-03-01 2020-12-18 Biose Compositions pour le traitement des candidoses
CN110225750A (zh) * 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 细菌性阴道病的治疗和预防方法
CN106692204B (zh) * 2017-03-10 2020-05-22 泰安大凡神农生物有限公司 一种缓解或改善盆腔炎症的益生菌组合物及其制备方法
CN106957811B (zh) * 2017-05-22 2019-11-26 山东神农医院管理有限公司 具有抑菌作用的格式乳杆菌与中药复方及其在治疗妇科炎症中的应用
DE102017113263A1 (de) 2017-06-16 2018-12-20 Lactopia GmbH Pharmazeutische Zusammensetzung enthaltend Bakterienstämme aus der Familie der Lactobacillaceae und Molke
CN110540945B (zh) * 2018-05-29 2023-04-25 广东强基药业有限公司 一种詹氏乳杆菌及其用于制备阴道抑菌药物的应用
IT201800020425A1 (it) 2018-12-20 2020-06-20 Univ Degli Studi Di Modena E Reggio Emilia Lattobacilli con attività antimicrobica
PE20220381A1 (es) * 2019-04-05 2022-03-18 Gedea Biotech Ab Formulacion de tableta vaginal
CN117180302B (zh) * 2023-11-06 2024-01-12 山东中医药大学第二附属医院(山东省中西医结合医院) 一种多糖在口腔粘膜修复中的应用及其所制备的促进剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6018644B2 (ja) * 1974-11-07 1985-05-11 財団法人成研会 膣坐薬の製造方法
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
US4591499A (en) * 1984-01-20 1986-05-27 J. B. Lima, Inc. Method for treatment and prevention of mastitis
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
HU214991B (hu) * 1991-01-17 1998-10-28 Ernő Méhész Komplett in vitro Lactobacillus tápközeget tartalmazó gyógyszerkészítmény és eljárás előállítására
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
IT1255522B (it) * 1992-09-24 1995-11-09 Ubaldo Conte Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita'
RU2031586C1 (ru) * 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
ZA942302B (en) * 1993-12-03 1995-09-29 Lafor Lab Ltd Viracidal bactericidal and spermicidal vaginal suppository
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
DE760848T1 (de) 1994-05-26 1997-08-28 Bracco Spa Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung
JP3962108B2 (ja) * 1995-04-03 2007-08-22 中外製薬株式会社 スクラルファート含有製剤組成物
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
CN1211188A (zh) * 1996-02-14 1999-03-17 普罗克特和甘保尔公司 用于泌尿生殖道和肠道疾病的组合物
JP4021951B2 (ja) * 1996-03-01 2007-12-12 わかもと製薬株式会社 乳酸菌を有効成分とする抗胃炎剤、抗潰瘍剤および醗酵食品

Also Published As

Publication number Publication date
PT956858E (pt) 2002-04-29
CA2254548A1 (en) 1999-10-30
ES2165139T3 (es) 2002-03-01
AU9240098A (en) 1999-11-11
HUP9802525A3 (en) 2000-06-28
AR017404A1 (es) 2001-09-05
HU9802525D0 (en) 1999-01-28
HUP9802525A1 (hu) 1999-12-28
KR100590839B1 (ko) 2006-06-19
DE69802260T2 (de) 2002-07-04
BR9900972A (pt) 2000-03-28
HU225491B1 (en) 2006-12-28
US6277370B1 (en) 2001-08-21
CA2254548C (en) 2009-07-14
JPH11322621A (ja) 1999-11-24
DE69802260D1 (de) 2001-12-06
PL189577B1 (pl) 2005-08-31
EP0956858A1 (en) 1999-11-17
PL329780A1 (en) 1999-11-08
HK1022439A1 (en) 2000-08-11
AU745286B2 (en) 2002-03-21
CN1263467C (zh) 2006-07-12
USRE39892E1 (en) 2007-10-23
EP0956858B1 (en) 2001-10-31
KR19990083612A (ko) 1999-11-25
CN1233474A (zh) 1999-11-03
ATE207755T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
DK0956858T3 (da) Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
EE200200038A (et) Konservitud farmatseutilised preparaadid
NO20005839D0 (no) Preparater for behandling av HIV og andre virale infeksjoner
NO20055010D0 (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20013507L (no) Blandinger for behandling av inflammatoriske reaksjoner
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
NO20015516D0 (no) Preparater og anvendelser av ET743 for behandling av kreft
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
PT1220858E (pt) Oxazinoquinolonas uteis para o tratamento de infeccoes virais
ATE298576T1 (de) Arzneizubereitungen
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
ATE237309T1 (de) Arzneizubereitungen
DK1049468T3 (da) Anvendelse af hydroxypyridonholdige pudderpræparater til behandling af skinnebens- og tryksår
AU4145999A (en) Topical drug for the treatment of viral infections